drugset / Trial / NCT04930991
High Dose Omeprazole in Patients With Pancreatic Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to test the safety of high dose omeprazole and see what effects that it has on patients with exocrine pancreatic cancer.
Timeline
- Start
- 2021-09-07
- Primary completion
- 2026-03-03
- Completion
- 2026-04-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omeprazole | Other / unclassified | 20 mg | Oral |
| Subject | Omeprazole | Other / unclassified | 80 mg | Oral |